Exosomal METTL16 from mesenchymal stem cells promotes malignant progression and M2 macrophage polarization in acute myeloid leukemia via IGF2BP2-dependent GPX1 m6A modification. // Biochimica et Biophysica Acta: Molecular Basis of Disease. – URL: https://www.sciencedirect.com/science/article/pii/S0925443926003248?dgcid=rss_sd_all
Exosomal METTL16 from mesenchymal stem cells promotes malignant progression and M2 macrophage polarization in acute myeloid leukemia via IGF2BP2-dependent GPX1 m6A modification. Biochimica et Biophysica Acta: Molecular Basis of Disease. https://www.sciencedirect.com/science/article/pii/S0925443926003248?dgcid=rss_sd_all
“Exosomal METTL16 from mesenchymal stem cells promotes malignant progression and M2 macrophage polarization in acute myeloid leukemia via IGF2BP2-dependent GPX1 m6A modification.” Biochimica et Biophysica Acta: Molecular Basis of Disease.
@article{article37635,
title = {Exosomal METTL16 from mesenchymal stem cells promotes malignant progression and M2 macrophage polarization in acute myeloid leukemia via IGF2BP2-dependent GPX1 m6A modification},
journal = {Biochimica et Biophysica Acta: Molecular Basis of Disease},
url = {https://www.sciencedirect.com/science/article/pii/S0925443926003248?dgcid=rss_sd_all}
}